About Us
Cellomatics Biosciences Ltd is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology, Immuno-oncology, Immunology, Inflammation and Respiratory therapeutic areas.
We provide bespoke pre-clinical/early discovery phase laboratory services to support biotechs, pharmaceutical companies and academic groups in their drug discovery projects. Our aim is to assist our clients in expediting their drug development programmes by providing high-quality, ethical services.
We provide bespoke pre-clinical/early discovery phase laboratory services to support biotechs, pharmaceutical companies and academic groups in their drug discovery projects. Our aim is to assist our clients in expediting their drug development programmes by providing high-quality, ethical services.
Cellomatics continually strives to offer added value to all our client discovery projects. We achieve this by constantly reviewing and evaluating new technologies that complement and augment our pre-clinical in vitro capabilities.
Key Facts
- Founded in 2015, Cellomatics Biosciences is a privately owned UK-based preclinical Contract Research Organisation (CRO).
- Headquartered in a purpose-built facility at Colwick Quays Business Park, Nottingham, serving clients across the biotechnology, pharmaceutical, and life sciences sectors worldwide.
- Specialises in human-relevant in vitro models, advanced cell-based bioassays, and translational biology services designed to reduce development risk and improve clinical predictability.
- Expertise spanning immunology, inflammation, respiratory disease, oncology, immuno-oncology, dermatology, gastrointestinal diseases, and regenerative medicine.
- Strong commitment to advancing human-relevant science and reducing reliance on animal testing through the development and application of innovative in vitro technologies.
- Experienced multidisciplinary scientific team, with the majority of scientists holding PhD qualifications and extensive industry and academic expertise.
- Comprehensive in-house capabilities including primary human cell models, immune cell functional assays, flow cytometry, multiplex cytokine analysis, high-content imaging, molecular biology, gene expression profiling, and protein biomarker analysis.
- Recipient of the Queen’s Award for Enterprise: International Trade (2022) in recognition of outstanding international growth.
- ISO-accredited organisation operating under robust quality systems, SOPs, and GLP-aligned processes
Our vision
To maximise the success of drug discovery projects
Our mission
We apply scientific and therapeutic expertise to develop innovative solutions that support and expedite the successful development of new therapies
Our values
Purposeful ambition: we are motivated to play our role in the development of new and better therapies for mankind
Innovative: we proactively combine the latest research techniques with our scientific and therapeutic expertise to develop niche and bespoke assays essential in drug development
Consultative: we work collaboratively as a team, and with our clients, sharing expertise and knowledge to help maximise success
Responsive: we are flexible and efficient, and clients can rely on us to deliver high-quality results quickly, helping them to achieve key milestones
Supportive: we foster a friendly environment where we can develop by learning from one another
Request a consultation with Cellomatics Biosciences today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact a member of the team.
